Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Half of patients treated with Breyanzi experienced complete remission, and a majority of these responses were durable.
For those with undetectable minimal residual disease, treatment discontinuation was as effective as staying on Imbruvica.
The injectable formulation can cut administration time from two or more hours to just five minutes.
Poorer outcomes for Black and Hispanic patients significantly depend on where they live.
Despite being the only current cure for MDS, transplants generally haven’t been offered to older patients.
The drug targets cancer’s survival proteins, making them more vulnerable to treatments that cause cancer cells to self-destruct.
Yescarta led to complete remission in people with advanced non-Hodgkin lymphoma.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.